Understanding and Helping Families: Parents With Psychosis

June 7, 2016 updated by: Lauren Stockton, University of Manchester

STAGE 1: Investigating Attributions and Expressed Emotion in Parents With and Without Psychosis STAGE 2: Investigating the Use of a Self-directed Parenting Programme With Parents Experiencing Psychosis

The purpose of this trial is to explore parent-child interactions in parents with and without psychosis, and ascertain whether a brief (10 week) supported self-help parenting program offered to parents in their own homes can help improve parents' self-efficacy and general well-being, as well as interpretations of their parent-child relationship and child behaviour in children who are 3-10 years old.

Study Overview

Detailed Description

The trial will be split into two stages.

Stage 1: Parents with no history of serious mental health problems and parents who have a history of psychosis or schizophrenia, who have children aged 3-10 years old, will take part in the Revised Five Minute Speech Sample (FMSS) and the Modified Camberwell Family Interview (CFI). They will also complete various measures looking at parental well-being, depression, anxiety and stress as well as parenting behaviours and interpretations of their child behaviour. In addition the PANSS interview will also be used. These interviews will be coded to investigate attributional patterns.

Stage 2: Parents who are experiencing psychosis, who took part in stage 1 will proceed to stage 2 if they want to. Parents will be seen weekly and take part in a guided self-help parenting intervention. This will require weekly visits over 10 weeks to the parents. During this time, symptoms, mood, general well-being and parenting behaviours will be monitored.

There will be no randomisation: all parents experiencing psychosis will receive the intervention.

Children do not attend the sessions, but it is hoped that parents practice the skills learned.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Lancashire
      • Manchester, Lancashire, United Kingdom, M139PL
        • Recruiting
        • The University of Manchester
        • Contact:
          • Lauren Stockton
          • Phone Number: 01613062619
        • Principal Investigator:
          • Lauren Stockton

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria for parents with psychotic illnesses

  1. Presence of ICD-10 schizophrenia-spectrum diagnosis (F20-29).
  2. Primary parental caregiver for index child. This includes 10 hours of contact time with their child.
  3. Over 18 years of age.
  4. Have at least one child aged 3-10 years old.
  5. Identify difficulties in parenting during assessment.
  6. Proficient in written and spoken English.
  7. Capacity to provide informed consent.

Exclusion Criteria for parents with psychotic illnesses

  1. Parents with a schizophrenia-spectrum diagnosis who have recently been discharged from acute in-patient care, and have less than four weeks of stabilisation. This will enable the individual sufficient time to readjust to living in the community and ensure symptom stabilisation before taking part in a study.
  2. Parents who have no regular contact with the index child or where there is known intention for their child to be removed.
  3. Parents who present with child protection of safeguarding issues.
  4. Parents seeking or receiving support from services regarding child management issues.
  5. Parents actively involved in other structured programmes.

Inclusion Criteria matched comparison group of parents for stage 1

The comparison group of parents will be matched for age, education, socioeconomic status and family composition where possible

  1. No previous history of psychotic illnesses.
  2. Primary parental caregiver for index child. This includes 10 hours of contact time with their child.
  3. Over 18 years of age.
  4. Have at least one child aged 3-10 years old.
  5. Identify difficulties in parenting during assessment.
  6. Proficient in written and spoken English.
  7. Capacity to provide informed consent.

Exclusion Criteria for comparison group

  1. Parents with schizophrenia-spectrum symptoms, diagnosis or history.
  2. Parents who have no regular contact with the index child or where there is known intention for their child to be removed.
  3. Parents seeking support from services regarding child management issues.
  4. Parents actively involved in other structured programmes.
  5. Parents/caregivers who do not have good working knowledge of English. They should have enough practical experience to be able to adequately use the English language to understand and respond to questions and to read and complete questionnaires.
  6. Insufficient language or cognitive ability to participant fully or provide informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Stage 2 Parents experiencing psychosis
Parents all receive the self-directed Triple P Positive Parenting Programme
10 week self-directed (guided) parenting intervention promoting self-belief, parenting confidence/self-efficacy and problem solving skills.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Positive and Negative Syndrome Scale (PANSS)
Time Frame: Initial Ax, Multiple Baseline Ax, Final Baseline Ax, 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up
Assessment of parental symptoms, mood, behaviours, aswell as social performance and depression
Initial Ax, Multiple Baseline Ax, Final Baseline Ax, 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up
Five Minute Speech Sample (FMSS)
Time Frame: Initial Ax, End Ax, Follow up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up
Assessment of Expressed Emotion using a 5 minute uninterrupted interview
Initial Ax, End Ax, Follow up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up
Modified Camberwell Family Interview (CFI)
Time Frame: Initial Ax only
In depth assessment of Expressed Emotion using a modified version of the CFI. This version is for parents of well children.
Initial Ax only

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression, Anxiety and Stress Scale (DASS-21)
Time Frame: Initial Ax, Multiple Baseline Ax, Final Baseline Ax, 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up
Self-reported depression, anxiety and stress using a short form scale
Initial Ax, Multiple Baseline Ax, Final Baseline Ax, 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up
Warwick-Edinburgh Mental Well-being Scale (WEMWBS)
Time Frame: Initial Ax, Final Baseline Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up
Self-reported general well-being
Initial Ax, Final Baseline Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up
Eyberg Child Behaviour Inventory (ECBI)
Time Frame: Initial Ax, Final Baseline Ax, 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up
Parents self-reported child problem behaviour
Initial Ax, Final Baseline Ax, 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up
Strengths and Difficulties Questionnaire (SDQ)
Time Frame: Initial Ax, Final Baseline Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up
Parents self-reported child behaviour assessing different aspects of behaviour, e.g.,: emotional symptoms, conduct problems, hyperactivity/inattention.
Initial Ax, Final Baseline Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up
Parenting and Family Adjustment Scale (PAFAS)
Time Frame: Baseline, 1, 5, 10, follow up
An assessment of parenting skills and family relationships.
Baseline, 1, 5, 10, follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lauren Stockton, The University of Manchester

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2015

Primary Completion (Anticipated)

July 1, 2017

Study Completion (Anticipated)

July 1, 2017

Study Registration Dates

First Submitted

November 20, 2015

First Submitted That Met QC Criteria

December 1, 2015

First Posted (Estimate)

December 4, 2015

Study Record Updates

Last Update Posted (Estimate)

June 8, 2016

Last Update Submitted That Met QC Criteria

June 7, 2016

Last Verified

June 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 15209: 15/NW/0532

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Schizophrenia

Clinical Trials on Triple P Positive Parenting Programme

Subscribe